Mustafa Shadi Rifaat Bashir, MD

Associate Professor of Radiology
Associate Professor in the Department of Medicine
Member of the Duke Cancer Institute
Campus mail Dept of Radiology, Box 3808, Durham, NC 27710
Phone (919) 684-7366
Email address mustafa.bashir@duke.edu

Hepatobiliary and pancreatic imaging
Liver cancer (hepatocellular carcinoma)
Fatty liver, NAFLD, and NASH
Chronic liver disease and cirrhosis
Pancreatic cancer
Technical development in MRI
Quantitative imaging

Education and Training

  • M.D., University of Iowa, 2004

Publications

Gondalia, Raj, Federica Vernuccio, Daniele Marin, and Mustafa R. Bashir. “The role of MR imaging in the assessment of renal allograft vasculature..” Abdom Radiol (Ny) 43, no. 10 (October 2018): 2589–96. https://doi.org/10.1007/s00261-018-1611-3.

PMID
29700591
Full Text

Elsayes, Khaled M., Ania Z. Kielar, Mohab M. Elmohr, Victoria Chernyak, William R. Masch, Alessandro Furlan, Robert M. Marks, et al. “White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI..” Abdom Radiol (Ny) 43, no. 10 (October 2018): 2625–42. https://doi.org/10.1007/s00261-018-1744-4.

PMID
30155697
Full Text

Moylan, Cynthia A., Patricia A. Sorrow, Alisha Mavis, Mustafa Bashir, Dereje Jima, Rachel Maguire, Erol Bozdogan, et al. “Obesity and Nonalcoholic Fatty Liver Disease in Childhood Associate with Altered DNA Methylation in Early Life.” In Hepatology, 68:949A-950A. WILEY, 2018.

Scholars@Duke

Kappus, Matthew R., Kara Wegermann, Katie Charles, Yuval Patel, Gemini Janas, Erol Bozdogan, Alice Parish, Donna Niedzwiecki, Andrew Joseph Muir, and Mustafa Bashir. “Use of Skeletal Muscle Index As a Predictor of Waitlist Mortality in Patients with End-Stage Liver Disease.” In Hepatology, 68:658A-659A. WILEY, 2018.

Scholars@Duke

Chaudhry, Mohammad, Cynthia A. Moylan, Michael S. Middleton, Alfredo Farjat, Kingshuk Roy Chaudhury, Cynthia D. Guy, Manal F. Abdelmalek, Rohit Loomba, Claude B. Sirlin, and Mustafa Bashir. “Quantifying the Placebo Effect on Liver Fat Using Magnetic Resonance Imaging-Proton Density Fat Fraction in NAFLD Clinical Trials.” In Hepatology, 68:68A-68A. WILEY, 2018.

Scholars@Duke

Harrison, Stephen A., James F. Trotter, Angelo H. Paredes, Cynthia D. Guy, Mustafa Bashir, Mark J. Jaros, Rajarshi Banerjee, et al. “NGM282 Rapidly Improves NAFLD Activity Score (NAS) and Fibrosis in 12 Weeks in Patients with Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH): Results of a Phase 2 Multi-Center Dose Finding Study.” In Hepatology, 68:66A-66A. WILEY, 2018.

Scholars@Duke

Harrison, Stephen A., Cynthia D. Guy, Mustafa Bashir, Juan Pablo Frias, Naim Alkhouri, Seth Baum, Rebecca A. Taub, et al. “In a Placebo-Controlled 36-Week Phase 2 Trial, Treatment with Mgl-3196 Compared to Placebo Results in Significant Reductions in Hepatic Fat (MRI-PDFF), Liver Enzymes, Fibrosis Biomarkers, Atherogenic Lipids, and Improvement in Nash on Serial Liver Biopsy.” In Hepatology, 68:9A-10A. WILEY, 2018.

Scholars@Duke

Vernuccio, Federica, Raj Gondalia, Susan Churchill, Mustafa R. Bashir, and Daniele Marin. “CT evaluation of the renal donor and recipient..” Abdom Radiol (Ny) 43, no. 10 (October 2018): 2574–88. https://doi.org/10.1007/s00261-018-1508-1.

PMID
29508012
Full Text

Elsayes, Khaled M., Victoria Chernyak, Ali I. Morshid, An Tang, Ania Z. Kielar, Mustafa R. Bashir, and Claude B. Sirlin. “Spectrum of Pitfalls, Pseudolesions, and Potential Misdiagnoses in Cirrhosis..” Ajr Am J Roentgenol 211, no. 1 (July 2018): 87–96. https://doi.org/10.2214/AJR.18.19781.

PMID
29932761
Full Text

Elsayes, Khaled M., Christine O. Menias, Ali I. Morshid, Akram M. Shaaban, Kathryn J. Fowler, An Tang, Victoria Chernyak, Janio Szklaruk, and Mustafa R. Bashir. “Spectrum of Pitfalls, Pseudolesions, and Misdiagnoses in Noncirrhotic Liver..” Ajr Am J Roentgenol 211, no. 1 (July 2018): 97–108. https://doi.org/10.2214/AJR.18.19820.

PMID
29932762
Full Text

Pages